JPH0114224B2 - - Google Patents

Info

Publication number
JPH0114224B2
JPH0114224B2 JP55039610A JP3961080A JPH0114224B2 JP H0114224 B2 JPH0114224 B2 JP H0114224B2 JP 55039610 A JP55039610 A JP 55039610A JP 3961080 A JP3961080 A JP 3961080A JP H0114224 B2 JPH0114224 B2 JP H0114224B2
Authority
JP
Japan
Prior art keywords
methyl
quinolone
hydrogen
melting point
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP55039610A
Other languages
English (en)
Japanese (ja)
Other versions
JPS55130960A (en
Inventor
Bikutaa Deebisu Roi
Fureizaa Jeemusu
Jon Nikoru Kenesu
Paakinson Reimondo
Buruyan Ieetsu Debitsudo
Furiiman Shimu Marukomu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boots Co PLC
Original Assignee
Boots Co PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co PLC filed Critical Boots Co PLC
Publication of JPS55130960A publication Critical patent/JPS55130960A/ja
Publication of JPH0114224B2 publication Critical patent/JPH0114224B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • C07D265/26—Two oxygen atoms, e.g. isatoic anhydride
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP3961080A 1979-03-27 1980-03-27 Quinolone compound Granted JPS55130960A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7910558 1979-03-27

Publications (2)

Publication Number Publication Date
JPS55130960A JPS55130960A (en) 1980-10-11
JPH0114224B2 true JPH0114224B2 (enExample) 1989-03-10

Family

ID=10504143

Family Applications (2)

Application Number Title Priority Date Filing Date
JP3961080A Granted JPS55130960A (en) 1979-03-27 1980-03-27 Quinolone compound
JP61316048A Granted JPS62215526A (ja) 1979-03-27 1986-12-24 降圧剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP61316048A Granted JPS62215526A (ja) 1979-03-27 1986-12-24 降圧剤

Country Status (10)

Country Link
JP (2) JPS55130960A (enExample)
BE (1) BE882443A (enExample)
CY (1) CY1343A (enExample)
ES (1) ES8104232A1 (enExample)
GB (1) GB2047691B (enExample)
GE (1) GEP19970835B (enExample)
JO (1) JO1072B1 (enExample)
MX (1) MX5950A (enExample)
SU (1) SU1124886A3 (enExample)
ZA (1) ZA801575B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA801575B (en) * 1979-03-27 1981-03-25 Boots Co Ltd Therapeutic agents
IE51542B1 (en) * 1980-09-26 1987-01-07 Boots Co Ltd Therapeutic agents
DE68917024D1 (de) * 1988-05-24 1994-09-01 Kirin Brewery 4(1H)-Chinolonderivate.
US8697674B2 (en) 2004-12-29 2014-04-15 Naturon, Inc. Xanthurenic acid derivative pharmaceutical compositions and methods related thereto

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA801575B (en) * 1979-03-27 1981-03-25 Boots Co Ltd Therapeutic agents

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS *
CHIM THER=1973 *

Also Published As

Publication number Publication date
GEP19970835B (en) 1997-02-10
BE882443A (fr) 1980-09-26
JPS62215526A (ja) 1987-09-22
CY1343A (en) 1987-01-16
ES489929A0 (es) 1981-04-16
ES8104232A1 (es) 1981-04-16
JO1072B1 (en) 1982-07-10
JPS55130960A (en) 1980-10-11
GB2047691A (en) 1980-12-03
GB2047691B (en) 1983-07-20
SU1124886A3 (ru) 1984-11-15
MX5950A (es) 1993-11-01
ZA801575B (en) 1981-03-25
JPH0250086B2 (enExample) 1990-11-01

Similar Documents

Publication Publication Date Title
US4302460A (en) 4-Quinolinones having antihypertensive activity
CS214891A3 (en) Thioxoheterocyclic compounds, process for their preparation and their use as medicaments
JPH0853447A (ja) 新規１，３−ジヒドロ−２Ｈ−ピロロ〔２，３−ｂ〕ピリジン−２−オンとオキサゾロ〔４，５−ｂ〕ピリジン−２（３Ｈ）−オン化合物、その製造方法及びそれらを含む薬剤組成物
EP0586560A1 (en) Novel benzopyrido piperidylidene compounds, compositions, methods of manufacture and methods of use
JPS6236382A (ja) チエノピリドン治療薬及びその製法
JPH0146514B2 (enExample)
JP4231107B2 (ja) 抗ウイルス作用を有する置換キノリン誘導体
JP3860618B2 (ja) 置換キノリン誘導体、それらの製造方法およびそれらの使用
US4390541A (en) Quinolone derivatives and their use in a method of controlling an immediate hypersensitivity disease
JPH0114224B2 (enExample)
IE840720L (en) Tetrazolylquinolinones
US4447435A (en) 3-Methylsulfonylmethyl-4-quinolinones useful for treating hypertension
NZ209193A (en) Substituted tetrazolyl quinolone derivatives and pharmaceutical compositions
AU630716B2 (en) Intermediates of 1-acyl-2,3-dihydro-4(1h)-quinolinone-4-oxime derivatives
IE61028B1 (en) Imidazole derivatives, process for their preparation and their use as alpha 2-adreno-receptor antagonists
EP0120484B1 (en) (1h-tetrazol-5-yl)tetrazolo (1,5-a)-quinolines and related compounds
GB2085441A (en) Therapeutic agents
WO2003004494A1 (en) Pyridazinone compound as adenosine antagonists
EP0216323A2 (en) Quinolonecarboxylic acid derivatives and their preparation
WO1996015127A1 (en) Pyridazinoquinoline compounds
JPS6160832B2 (enExample)
HU184968B (en) Process for preparing quinolone derivatives
CS228519B2 (cs) Způsob výroby nových chinolonů
CS221907B2 (cs) Způsob přípravy 3-(alkylthio, alkylsulfinyl nebo alkylsulfonyl)-4-chinolonů
JPS6152833B2 (enExample)